Bristol Myers Squibb to Acquire Mirati Therapeutics in Deal Worth Up to $5.8 Billion
The deal expands the pharmaceutical company’s portfolio of cancer drugs. Source link
Cancer Drugs
Merck Challenges U.S. Government’s New Powers to Negotiate Drug Prices
The drugmaker filed a lawsuit saying Medicare’s drug-price negotiation program violates the company’s constitutional rights. Source link
FDA Allows Imports of China-Made Chemotherapy to Ease U.S. Shortage
HealthIn temporary move, Chinese drugmaker will be able to ship its cisplatin chemotherapy even though it hasn’t been FDA approved...
Moderna, Merck Show Progress Toward Cancer Vaccines
An mRNA shot helped prevent relapse in high-risk melanoma patients. Source link
Biotech Co-Founder, Facing Murder-for-Hire Charges, Accused of Fabricating Data
Enochian BioSciences Inc. has sued co-founder Serhat Gumrukcu for contractual fraud, alleging that it paid him and his husband $25...
Bristol-Myers to Buy Turning Point Therapeutics for $4.1 Billion
Bristol-Myers Squibb Co. said it will acquire biotechnology company Turning Point Therapeutics Inc. TPTX 116.76% for $4.1 billion, an effort...
Moderna Seeks to Dismiss Covid-19 Vaccine Patent Lawsuit
Moderna Inc. is trying to fend off rival companies’ claims that its Covid-19 vaccine infringes their patents, arguing that the...
